PHARMACOLOGY M1.1 - 1.2 Flashcards

1
Q

can be defined as the study of substances that interact with living systems through chemical processes. These interactions usually occur by binding of the substance to regulatory molecules and activating or inhibiting normal body processes. These substances may be chemicals administered to achieve a beneficial therapeutic effect on some process within the patient or for their toxic effects on regulatory processes in parasites infecting the patient.

A

Pharmacology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

study of drugs

A

Pharmacology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

is the body of knowledge concerned with the action of chemicals on biologic systems.

A

Pharmacology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2 Nature of drug

A

Pharmacodynamics and pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

receptor, receptor sites and inert binding sites

A

Pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

movement of drugs in body, absorption, distribution, metabolism, elimination

A

Pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

4 Drug development and regulation

A
  • safety and efficacy
  • animal testing
  • clinical trials
  • Patients and generic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

is defined as the science of substances used to prevent, diagnose, and treat disease.

A

MEDICAL PHARMACOLOGY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

is the branch of pharmacology that deals with the undesirable effects of chemicals on living systems, from individual cells to humans to complex ecosystem.

A

TOXICOLOGY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

the science of medical use of drugs, was developed as the precursor to pharmacology

A

Materia Medica

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

developed the methods of experimental physiology and pharmacology

A

Francois Magendie and his student Claude Bernard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

It may be defined as any substance that brings about a change in biologic function through its chemical actions.

A

Drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

activator of a specific molecule

A

Agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

inhibitor of a specific molecule

A

Antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

“the target molecule” for drug

A

Receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A drug may be synthesized within the body

A

HORMONES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

it may be chemicals not synthesized in the body

A

Xenobiotics - “stranger”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

refers to a drug that have almost exclusively harmful effects

A

poison

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

The dose of the drug makes the poison

A

Paracelsus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Full name of Paracelsus

A

theophrastus phillipus auroleus bosbastus von hohenheim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

may be solid, liquid or gas. It may be organic or inorganic.

A

Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

very strong; not reversible. Aspirin (acetyl group) and cyclooxygenase is an example of this type of interaction

A

Covalent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

weaker than covalent; vary from relatively strong linkages between permanently charged ionic molecules to weaker hydrogen bonds and very weak induced dipole forces

A

Electrostatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

usually quite weak; it is the interaction of highly lipid-soluble drugs with the lipids of the cell membrane

A

Hydrophobic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

beta-blocker

A

chirality (stereoisomerism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

is a potent beta blocker

A

(S)(-) isomer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

is a hundred fold weaker at the beta receptor

A

(R)(+) isomer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

of ketamine is more potent and is less toxic

A

(+) enantiomer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q
  • Is the study of how the body absorbs, distributes, metabolizes, and excretes drugs
  • What the body does to the drug
A

PHARMACOKINETICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q
  • It includes the measurement of responses to drugs and how response relates to drug dose or concentration
  • Describes the action of drugs
  • What the drug does to the body
A

PHARMACODYNAMICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

– the study of the use of drugs to treat diseases.

A

PHARMACOTHERAPEUTICS (PHARMACOTHERAPY)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

PHARMACOTHERAPEUTICS (PHARMACOTHERAPY)
use of drug treatment is to:

A
  • Cure a disease
  • Delay disease progression
  • Alleviate the signs and/or symptoms of the disease
  • Facilitate nonpharmacologic therapeutic intervention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

is the study of the relationship of genetic factors to variations in drug response

A

PHARMACOGENETICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

is the study of the cost effectiveness of drug treatments

A

PHARMACOECONOMICS

35
Q

is the study of the effect of drugs on population

A

PHARMACOEPIDEMIOLOGY

36
Q

study of drug’s adverse effects

A

TOXICOLOGY

37
Q

is the study of a poison, usually one produced by or occurring in a plant or microorganism

A

TOXINOLOGY

38
Q

study of doses

A

POSOLOGY

39
Q

study of drug’s manufacture, preparation and dispensing of drugs

A

PHARMACY

40
Q

is the study of preparing and dispensing drugs

A

PHARMACEUTICS

41
Q

is the study of the identification and preparation of crude drugs from natural sources

A

PHARMACOGNOSY

42
Q

the science of drug preparation and the medical use of drugs

A

MATERIA MEDICA

43
Q

is the application of all principles in pharmacy to humankind

A

CLINICAL PHARMACY

44
Q

Four pharmacokinetic properties determine the onset, intensity, and the duration of drug action

A

ADME

45
Q

from the site of administration permits entry of the drug (either directly or indirectly) into plasma.

A

Absorption

46
Q

the drug may then reversibly leave the blood- stream and distribute into the interstitial and intracellular fluids.

A

Distribution

47
Q

the drug may be biotransformed by metabolism by the liver or other tissues.

A

Metabolism

48
Q

the drug and its metabolites are eliminated from the body in urine, bile, or feces.

A

Elimination

49
Q

ADME Explained

A

Absorption, distribution, metabolism, excretion

50
Q

For a chemical compound to become a marketable drug, that compound must have favourable properties in addition to efficacy (its therapeutic effect) and safety.

A

Absorption, Distribution, Metabolism and Excretion

51
Q
  • A compound’s ability to pass through barriers such as the intestinal lining, the nasal lining, the lungs or the skin.
A

ABSORPTION

52
Q
  • How the compound is distributed around the body and its propensity to accumulate in certain tissues or organs.
A

DISTRIBUTION

53
Q
  • How the body breaks down the compound, normally by the liver. The key issues are drug-drug interactions, and the effects of the metabolites (the new chemicals created as a result of metabolism).
A

METABOLISM

54
Q
  • The rate and process through which the compound exits the body.
A

EXCRETION

55
Q

route, get into the system rapidly and more efficiently

A

INTRAVASCULAR

56
Q

not undergo absorption since it is administered directly into the systemic circulation

A

IV

57
Q

(oral, peroral, rectal, etc) need to undergo a liberation process (depending on the dosage form used) prior to absorption. Drugs that undergo absorption, especially via the GI tract need to be in solution.

A

extravascular

58
Q

Explain difference between oral and peroral

A

peroral-direct swallowing the absorption is stomach
oral-inside the mouth the absorption is mouth cavity

59
Q

drug molecules cross the biological membrane more rapidly and efficiently than the ionized, more polar moieties.

A

Small, nonionic, and lipophilic

60
Q

is the process by which a drug leaves the systemic circulation and enters the various compartments (tissue compartments).

A

Disposition

61
Q

collective term of distribution, metabolism, elimination

A

Disposition

62
Q

e.g. CNS, heart, etc

A

distribution

63
Q

which organ undergo metabolism and excretion

A

liver

64
Q

for excretion

A

kidneys

65
Q

process terminates the action of the drug by promoting its CLEARANCE

A

ELIMINATION

66
Q

Meaning ng CLEARANCE

A

total volume that will undergo excretion

67
Q

provides the fundamental concept of the PK characteristics of drugs based on the degree of ionization as influenced by pH.

A

Henderson-Hasselbalch equation

68
Q
  • At low pH (acid environment) weak acids are in their unionized form.
  • The unionized form is more lipophilic, and thus can cross the membrane rapidly and efficiently through passive diffusion.
  • Weak acids remain unionized in the acid region of the GIT (stomach), thus optimum absorption occurs in this area.
  • At high pH (basic environment) weak acids become ionized, thus more polar in character.
  • Excretion is favorable when the drug is in its ionized form.
A

WEAK ACIDS

69
Q
  • are best absorbed in the alkaline region of the GIT (small intestines) because they are in their unionized form. As mentioned earlier, unionized moieties are nonpolar and lipophilic, so can cross the membranes more efficiently.
  • To promote the excretion of weak bases, an acid environment (low pH) is desired since it could make alkaline drugs become more ionized. More ionized forms of the drug are polar and less lipophilic (hydrophilic), and thus are excretable.
  • Permeation across the membrane is an important PK principle that determines the ability of the drug to reach circulation and be distributed to various organs and reach its site of action.
A

WEAK BASES

70
Q

This law describes the passive flux of molecules down a concentration gradient (from a region of higher concentration to a region of lower concentration)

A

FICK’S LAW

71
Q

against the concentration gradient

A

active transport system

72
Q

along the concentration gradient

A

passive

73
Q

utilized a carrier or transporter to cross the membrane

A

active transport and facilitated diffusion (carrier-mediated)

74
Q

Vesicular transport is a mechanism of drug permeation that involves the engulfment of impermeant molecules by the vesicles in the cell membrane via

A

endocytosis (pinocytosis or phagocytosis)

75
Q

Vesicular transport release into the cell, and expulsion of the material via

A

membrane vesicles (exocytosis)

76
Q

Meaning disintegration and dissolution

A

disintegration - time
dissolution - amount

77
Q

vesicular transport system - liquid

A

pinocytosis

78
Q

vesicular transport system - large molecules

A

phagocytosis

79
Q

drug leaves systemic circulation

A

disposition

80
Q

med for diabetic to block carbohydrates after ng first na subo inom ng gamot

A

acarbose

81
Q

well-closed container
paghindi magvovolatilized
no API

A

nitrostat

82
Q

The next event leads to understanding how drugs work at the organ and tissue levels, real advances in basic pharmacology during this time were accompanied by an outburst of unscientific claims by manufacturers and marketers of worthless

A

“patent medicines.”

83
Q

The molecular mechanisms of action of many drugs have been

A

identified, and numerous receptors have been isolated, structurally characterized, and cloned

84
Q

It is the relation of the individual’s genetic makeup to his or her response to specific drugs. This leads to several advances in therapeutics such as:

A

1) Investigation of small interfering RNAs (siRNAs) and microRNAs (miRNAs) as therapeutic agents

2) Short nucleotide chains called antisense oligonucleotides (ANOs), were synthesized to be complementary to natural RNA or DNA